{
  "retracted": false,
  "timestamp": 1569369600000,
  "updates": [
    {
      "timestamp": 1569397356713,
      "identifier": {
        "doi": "10.3389/fonc.2019.00967"
      },
      "type": "corrigendum"
    }
  ],
  "identifier": {
    "doi": "10.3389/fonc.2019.00707"
  },
  "journal": "Frontiers in Oncology",
  "publisher": "Frontiers Media SA",
  "title": "Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution"
}
